Clinical Trials Browser

Unknown × INDUSTRY × Recurrence × Clear all

NCT06149169 2024-08-21

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

Phase 2 Unknown

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT06564363 2024-08-21

The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Recurrence

NCT03275493 2024-05-28

CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06292858 2024-03-05

Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors

Phase 1 Unknown

Neoplasm Metastasis, Recurrence

NCT05861947 2024-01-31

JIVAN

Phase 1 Unknown

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Colonic Neoplasms, Esophageal Neoplasms, Kidney Neoplasms, Recurrence, Stomach Neoplasms

NCT05415475 2024-01-05

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

Phase 1 Unknown

Gastrointestinal

Esophageal Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence, Stomach Neoplasms, Colorectal Neoplasms

NCT04089215 2023-11-24

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT06074107 2023-10-11

Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects

Phase 2 Unknown

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT04825496 2023-09-21

Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02825836 2023-07-13

Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05920876 2023-06-27

A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma

Phase 1 Unknown

Multiple Myeloma, Recurrence

NCT05487651 2023-05-18

ANCHOR2

Phase 1 Unknown

LymphoidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT03510767 2023-04-14

A Study of TQ-B3525 on Tolerance and Pharmacokinetics

Phase 1 Unknown

Lymphoma, Recurrence

NCT04749355 2023-03-09

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Phase 2 Unknown

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT04933825 2023-02-17

A Study of ET-02 in Patients With Relapsed or Refractory B-cell Malignancy(NHL/ALL)

Phase NA Unknown

Recurrence

NCT05727683 2023-02-14

CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05693831 2023-01-23

myCare-102

Neoplasms, Recurrence

NCT05007418 2023-01-17

Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma

Phase 1 Unknown

Multiple Myeloma, Recurrence

NCT05557903 2022-09-28

Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL

Phase 1 Unknown

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, T-Cell

NCT05150457 2022-09-27

Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Neoplasm Metastasis, Neoplasms, Recurrence

NCT04962529 2022-08-11

Breast Cancer Liquid Biopsy Trial

Breast Neoplasms, Neoplasms, Recurrence

NCT04861779 2022-08-03

A Study of HSK29116 in Adults With Relapsed/Refractory B-cell Malignancies

Phase 1 Unknown

Recurrence

NCT05363800 2022-07-29

Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma

Phase 1 Unknown

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Recurrence

NCT05212584 2022-07-06

CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05426798 2022-06-22

Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes

Phase 1 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute

NCT04865458 2022-05-06

A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic Malignancies

Phase 1 Unknown

Recurrence

NCT05155839 2022-02-22

Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL)

Phase 1 Unknown

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, B-Cell

NCT05236621 2022-02-11

A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Phase 3 Unknown

Multiple Myeloma, Recurrence

NCT05223686 2022-02-04

To Evaluate the Safety and Tolerability of Human CD19-CD22 Targeted T Cells Injection for Subjects With R/R B-ALL.

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05052970 2022-02-01

Mitoxantrone Hydrochloride Liposome Injection, Bortezomib and Dexamethasone in the Treatment of R/R MM

Phase 1 Unknown

Multiple Myeloma, Recurrence

NCT05100303 2021-10-29

A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)

Phase 1/2 Unknown

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT04948788 2021-09-28

SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma

Phase 2 Unknown

Recurrence, Lymphoma, B-Cell

NCT04689308 2021-09-08

This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies

Phase 1 Unknown

Recurrence

NCT04458389 2021-08-13

A Phase 1/2 Study of TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory Lymphomas

Phase 1/2 Unknown

Lymphoma, Recurrence

NCT04984434 2021-07-30

Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Unknown

Multiple Myeloma, Recurrence

NCT02785250 2021-06-18

Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer

Phase 1/2 Unknown

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasms, Recurrence

NCT04003168 2021-03-01

Human BCMA Targeted T Cells Injection Therapy for BCMA-positive Relapsed/Refractory Multiple Myeloma

Phase 1 Unknown

Multiple Myeloma, Recurrence

NCT03265106 2021-02-04

A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects

Phase 1/2 Unknown

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT04204161 2021-02-04

A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma

Phase 1 Unknown

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT04108325 2021-01-28

A Phase Ib Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

Phase 1 Unknown

Recurrence, Lymphoma, T-Cell, Peripheral

NCT04626752 2020-11-13

CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase EARLY_PHASE1 Unknown

Multiple Myeloma, Recurrence

NCT04623333 2020-11-10

A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms, Recurrence

NCT03825146 2020-02-24

AMPCAL

Phase 1 Unknown

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT02387879 2019-09-26

A Non-interventional,Observational Post Authorization Study of Patients With Multiple Myeloma Treated With Lenalidomide TR

Multiple Myeloma, Recurrence

NCT04056975 2019-08-14

A-319

Phase 1 Unknown

Recurrence, Lymphoma, B-Cell

NCT01211457 2019-07-16

Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

Phase 1/2 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute

NCT00772317 2019-04-10

STAR

Phase NA Unknown

Prostatic Neoplasms, Recurrence

NCT03000335 2019-02-04

Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk

Burkitt Lymphoma, Recurrence

NCT03776279 2018-12-14

A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma

Phase 2 Unknown

Recurrence, Lymphoma, Extranodal NK-T-Cell

NCT03661554 2018-09-10

BCMA CAR-T

Phase EARLY_PHASE1 Unknown

Multiple Myeloma, Recurrence